Ifunanya Igbojekwe
About Ifunanya Igbojekwe
Harvard Airborne IC Course Participant
Role(s) / Profession(s)
- Epidemiologist
- Laboratory Professional
- Monitoring & Evaluation Professional
Organization
- Family Health International - FHI
Work Location(s)
- Nigeria
Language(s)
- English
Recent Contributions
-

Ifunanya Igbojekwe replied to "Disposal of sputum for home infection control in MDR TB treatment" in the TB Infection Control community.
Dear all, Discussions on TB Infection control erupts interesting line of thoughts. I am wondering if and what the role of temperature aerosolization of sputum collected in a container would be when the patients reopens the container for subsequent sputum deposition? Or are they being asked to use fresh containers ...
-

Ifunanya Igbojekwe replied to "distance between patients_hospitalization & waiting area" in the TB Infection Control community.
Dear all, Great comments. More like a refresher training for me. I just want to include and also remind us of what Tariq taught us during the course this year; due to the difficulty of ensuring that the hospital staff adhere to the "low density" TB patients in the ward, ...
-

Ifunanya Igbojekwe replied to "Effectiveness of GPS for following study participants" in the [ARCHIVED] Adherence & Retention community.
Dear Jessica, attn: Chinenye, I have been following up with the discussion "Effectiveness of GPS for following study participants". I must say it is a very interesting one. I have however, wondered the feasibility of this in practical terms. I understand you are conducting a study which you must have ...
-

Ifunanya Igbojekwe replied to "Defining LTFU" in the [ARCHIVED] Adherence & Retention community.
Dear Rebecca, Your concern about the definition of LTFU is valid because the approach to adherence and retention issues will largely depend on how LTFU is defined. In Nigeria, LTFU is been defined as Patient defaulting up to 3 consecutive months of ARV refill appointment. However, in order to ensure ...
Recent Recommendations
- None at this time.
